Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC

Stopped Ph I completed. Funding became unavailable causing Ph II to cease after two patients were enrolled.

Conditions

• Lung Cancer

Interventions

• DRUG: carboplatin
• DRUG: nab-paclitaxel
• RADIATION: Radiation therapy

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

• [object Object]